H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Census population 134,023. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Haven clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Haven storefront.
Sports Recovery Treatment Options in New Haven, CT for clinics & physicians. Accelerate sports recovery wi… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of sports recovery treatments in New Haven: (1) CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. (2) Connecticut Part B wound biologics are reviewed by National Government Services (NGS) under JK, shared with MA, ME, NH, NY, RI, VT. We help with the second file. We do not pretend to be a New Haven storefront.
National Sports Recovery Treatment Options notes (how the product actually works)Three grains, kept separate on purpose. City: Census 134,023 and CDC PLACES crude rates. State: Connecticut Department of Public Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and National Government Services (NGS) LCDs. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a New Haven trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 11.7% of adults in New Haven have diagnosed diabetes — 0.3 points below the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 11.7% of adults — 0.3 points below the U.S. 12% figure. Obesity is 37.9%; arthritis is 20.3%. That is place-level BRFSS modeling, not a clinic census and not a New Haven trial.
Connecticut is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in New Haven.
Bring specialty, monthly joint / regenerative volume, and whether you bill JK FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 11.7% diabetes and 20.3% arthritis for New Haven — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in New Haven, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Haven is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Haven — 0.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Haven. Useful for joint-program math; still needs a diagnosis and privileging.
No New Haven storefront. Joe Bradley is an active practice owner. sports recovery treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.